Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Ovorex** is a marketed Siddha herbal softgel-capsule formulation from SKM Siddha and Ayurvedha Company. The manufacturer describes it as a women’s-health product intended to treat tubal block and control pelvic pain. Each 1,000 mg softgel capsule is listed as containing Adutheendapalai (*Aristolochia bracteata*) 49.75%, Seeragam (*Cuminum cyminum*) 0.50%, and Amanakku ennai listed by the manufacturer as *Sesamum indicum* 49.75%. The product is intended for oral use under medical supervision. ([skmsiddha.com](https://skmsiddha.com/estore/shop-page/ovorex-softgel-capsules-10x10-100nos-1000mgm))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ovorex.